News | April 10, 2026
Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
He brings extensive cross-functional expertise built through leadership roles
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
Under the deal, Hims & Hers will offer patients access to FDA-approved versions of Ozempic and Wegovy at the same self-pay prices available through other telehealth platforms
Starting January 1, 2027, Lilly’s Zepbound (tirzepatide), Mounjaro (tirzepatide), and orforglipron, if approved, will be available through participating Medicare Part D plans
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
Subscribe To Our Newsletter & Stay Updated
